Tempany, Clare M.
Brigham and Women's Hospital,
United States
2024 Rank: 63551
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 478 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63551 | 64944 |
| Total Cites | 18486 | 21003 |
| H-index | 59 | 66 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1544 | 1715 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 4335 | 4967 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14647 | 15769 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.33 |
| Self-Citation Percentage |
11.98%
|
|
Tempany, Clare M.
Harvard Medical School,
United States
2022 Rank: 59196
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 458 out of 105572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59196 | 61457 |
| Total Cites | 14795 | 16946 |
| H-index | 56 | 61 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 30 | 31 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1424 | 1583 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 3959 | 4549 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11593 | 12536 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.35 |
| Self-Citation Percentage |
12.69%
|
|
Tempany, Clare M.
Harvard Medical School,
United States
2021 Rank: 58730
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 462 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58730 | 60816 |
| Total Cites | 13899 | 15929 |
| H-index | 55 | 59 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1373 | 1526 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 3819 | 4392 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10891 | 11779 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.35 |
| Self-Citation Percentage |
12.74%
|
|
Tempany, Clare M.
Brigham and Women's Hospital,
United States
2020 Rank: 58743
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 465 out of 84246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58743 | 58837 |
| Total Cites | 11938 | 13801 |
| H-index | 52 | 56 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 29 | 30 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1311 | 1461 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 3600 | 4159 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9318 | 10116 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.36 |
| Self-Citation Percentage |
13.50%
|
|